Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs)
$107.21
pos +0.51
+0.48%
Today's Range: 106.60 - 107.25 | JNJ Avg Daily Volume: 7,828,800
Last Update: 11/26/14 - 4:01 PM EST
Volume: 5,503,702
YTD Performance: 17.05%
Open: $106.77
Previous Close: $106.70
52 Week Range: $86.09 - $109.49
Oustanding Shares: 2,799,110,362
Market Cap: 298,665,075,625
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 4
Moderate Buy 3 3 3 3
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.19 2.19 2.19 2.27
Latest Dividend: 0.70
Latest Dividend Yield: 2.62%
Dividend Ex-Date: 11/21/14
Price Earnings Ratio: 17.67
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
17.67 17.70 25.98
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.64% 12.78% 74.98%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.10 0.16 0.05
Net Income 31.50 0.04 0.01
EPS 24.60 0.01 0.00
Earnings for JNJ:
EBITDA 23.06B
Revenue 71.31B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.25 $1.52 $5.96 $6.20
Number of Analysts 9 5 11 13
High Estimate $1.28 $1.61 $6.03 $6.49
Low Estimate $1.21 $1.39 $5.91 $6.00
Prior Year $1.24 $1.54 $5.52 $5.96
Growth Rate (Year over Year) 0.99% -1.04% 8.05% 3.90%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Americans are living much longer these days -- and there are a number of ways to invest.
Welcome back to the airlines and the biotechs.
Investing during a mid-term election can offer large returns.
There is a disconnect between stock prices and intrinsic value.
Bearish
Oct 15, 2014 | 8:36 AM EDT
Shares of JNJ now seen reaching $99, according to Bank of America/Merrill Lynch. Estimates also cut, as the company is facing multiple ...
It doesn't stop even as some of these pullbacks are irrational.
There may be a wave of consolidation.
Because it's completely hit or miss.
I am disappointed by the lack of scoops and against-the-grain research.
Overbought levels suggest decline is headed lower.

Columnist Conversations

Kass:
Monitise has announced the sale of additional stock to Telefonica, Santander and Master Card. Expands relation...
Lang:
Lights, Camera, ACTION! This move lately in GPRO has been stellar, up nearly 12% over the past couple of sess...
For just under two weeks MCD has been bumping up against a very solid wall of resistance. The $96.95 to ...
Texas Instruments is surging today. Shares are up over 2.7% and are moving further into new 52W high gro...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.